FineHeart

FineHeart Selected as One of The Top Ten Cardiac Abstracts to present at the 66th Annual ASAIO Conference

Bordeaux, France (June 8, 2021) – FineHeart S.A, a preclinical medical device company that has developed the ICOMS FLOWMAKER®, an Implantable Cardiac Output Management System designed to address the unmet need of patients suffering from severe heart failure, today announced that it has been chosen to present at the 66th annual ASAIO conference, which will take place on June 10 -12 at the Hilton DC Hotel in Washington, DC.

FineHeart Successfully Raises €15 million Series B funding With Industrial and Independent Investors

FineHeart Successfully Raises €15 million Series B funding With Industrial and Independent Investors The First In Human implantation of the ICOMS FLOWMAKER® is assured following this financing French Version English Version

FineHeart breaks new ground with successful removal of the ICOMS FLOWMAKER® in a 90-day in-vivo trial

FineHeart breaks new ground with successful removal of the ICOMS FLOWMAKER® in a 90-day in-vivo trial Towards a new standard for device indication: Implantation for temporary or permanent use. French Version English Version

Wireless Transcutaneous Energy Transfer (TET) System for powering its ICOMS FLOWMAKER® Heart Pump

Wireless Transcutaneous Energy Transfer (TET) System for powering its ICOMS FLOWMAKER® Heart Pump A major step and a critical milestone achieved prior to First In Human clinical trials. We are delighted to have succeeded in this major technological advancement proving the ability to power a Cardiac Assist device via an intelligent and minimally invasive TET… Poursuivre la lecture de Wireless Transcutaneous Energy Transfer (TET) System for powering its ICOMS FLOWMAKER® Heart Pump

Miniaturized Heart Pump

Miniaturized Heart Pump FineHeart Achieves Milestone For its Miniaturized Heart Pump Technology with Successful Completion of 30-Day Preclinical Study This in vivo study is a significant milestone as we work towards first-in-human clinical trials and prove ICOMS FLOWMAKER® technology as a potential game-changer in saving patients from heart failure Arnaud Mascarell Founder & Chief Executive… Poursuivre la lecture de Miniaturized Heart Pump

FineHeart Completes First Successful Chronic In-Vivo Study of its ICOMS Device Intended for the Treatment of Severe Heart Failure

FineHeart, a French medical device company, today announced the success of a seven-day preclinical study to evaluate its Implantable Cardiac Output Management System (ICOMS), the first fully Intra-Ventricular Flow Accelerator synchronized to the native heartbeat to restore natural heart pumping capacity.